Amarin reported $1.43M in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
DBV Technologies DBVT:US USD -18020000 5.8M
Aerie Pharmaceuticals AERI:US USD -26672000 8.54M
Alnylam Pharmaceuticals ALNY:US USD -258040000 66.35M
Amarin AMRN:US USD 1.43M 39.05M
AstraZeneca AZN:LN USD 2.26B 427M
Biocryst Pharmaceuticals BCRX:US USD -17445000 17.28M
Esperion Therapeutics ESPR:US USD -41623000 10.75M
GlaxoSmithKline GSK:LN GBP 2.41B 591M
Halozyme Therapeutics HALO:US USD 83.69M 49.63M
Intercept Pharmaceuticals ICPT:US USD -10144000 3.22M
IONIS PHARMACEUT IONS:US USD -59154000 26.36M
JAZZ PHA JAZZ:US USD 199.21M 72.86M
Nektar Therapeutics NKTR:US USD -37471000 10.24M
Neurocrine Biosciences NBIX:US USD 87.8M 33.1M
Novartis NOVN:VX USD 3.33B 8M
Teva Pharmaceutical Industries TEVA:US USD 740M 6M